Franklin Biotechnology Discv N(acc)USD

Performance History30/06/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv N(acc)USD
Fund101.247.739.5-28.19.0
+/-Cat6.23.6-4.10.9-4.4
+/-Idx-5.93.2-4.7-5.6-1.3
 
Key Stats
NAV
26/07/2017
 USD 28.18
Day Change 0.82%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0122613499
Fund Size (Mil)
30/06/2017
 USD 2408.64
Share Class Size (Mil)
30/06/2017
 USD 165.91
Max Initial Charge 3.00%
Ongoing Charge
27/01/2017
  2.59%
Investment Objective: Franklin Biotechnology Discv N(acc)USD
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns26/07/2017
YTD13.43
3 Years Annualised15.34
5 Years Annualised28.28
10 Years Annualised20.16
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Steven Kornfeld
15/09/2015
Inception Date
29/12/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv N(acc)USD30/06/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks96.460.0096.46
Bonds0.000.000.00
Cash2.310.002.31
Other1.230.001.23
Top 5 Regions%
United States97.12
Middle East0.83
United Kingdom0.69
Eurozone0.58
Canada0.48
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.69
Alexion Pharmaceuticals IncHealthcareHealthcare7.67
Incyte CorpHealthcareHealthcare5.88
Regeneron Pharmaceuticals IncHealthcareHealthcare5.56
Biogen IncHealthcareHealthcare4.75
Franklin Biotechnology Discv N(acc)USD